Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 September 2020 | Story Dr Nitha Ramnath | Photo Supplied
Devina Harry Kader Asmal Fellowship
The UFS’ Devina Harry was accepted into the Kader Asmal Fellowship Programme.

The UFS’ own Devina Harry is set to travel to Ireland in September 2020 to begin a year-long Fellowship Programme for a Master of Business. As one of 20 students selected from the African continent, Devina was recently accepted into the Kader Asmal Fellowship Programme, which affords her the opportunity to study in Ireland during the 2020/21 academic year.

A research assistant in the Department of Business Management, Devina holds an Honours in Marketing. “I am very grateful to be awarded this scholarship and excited about this new journey,” says Devina, who is scheduled to begin the programme in October 2020. “I hope to come back to South Africa and contribute to my field of study,” she says.

Devina went through a rigorous application process and had to meet the criteria for selection, one of which is having a minimum average grade point of 75% for her honours.

Prof Brownhilder Nene, Head of Department: Business Management, gave Devina some words of encouragement: “You will never know how far you can go unless you try. Thank you, Devina, for stepping out of your comfort zone and getting this scholarship.” 

The Kader Asmal Fellowship Programme is a South African strand of a broader Ireland-Africa Fellows Programme managed by the Irish Department of Foreign Affairs and Trade. It was set up in 2012 in honour of the late Professor Kader Asmal, and is a fully-funded scholarship opportunity for those who want to develop skills and knowledge to contribute to the achievement of the Sustainable Development Goals in South Africa.

News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 

When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?

Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept